2023-2029 Global Phospholipids in Pharmaceutical Industry Research & Trends Analysis Report
According to YH Research, the global market for Phospholipids in Pharmaceutical should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
China Phospholipids in Pharmaceutical market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
The United States Phospholipids in Pharmaceutical market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
In terms of source, Soy segment holds a share about % in 2022 and will reach % in 2029; while in terms of application, Oral Products has a share approximately % in 2022 and will grow at a CAGR % during 2023 and 2029.
The global key manufacturers of Phospholipids in Pharmaceutical include Cargill, Avril, Croda, Lipoid, Nippon Fine Chemical, Sonic Biochem, Nabros Pharma, Vav and NOF, etc. In 2022, the global top five players hold a share approximately % in terms of revenue.
In pharmaceutical formulations, phospholipids obtained from plant or animal sources and synthetic phospholipids are used. Natural phospholipids are purified from, e.g., soybeans or egg yolk using non-toxic solvent extraction and chromatographic procedures with low consumption of energy and minimum possible waste. Because of the use of validated purification procedures and sourcing of raw materials with consistent quality, the resulting products differing in phosphatidylcholine content possess an excellent batch to batch reproducibility with respect to phospholipid and fatty acid composition. The natural phospholipids are described in pharmacopeias and relevant regulatory guidance documentation of the Food and Drug Administration (FDA) and European Medicines Agency (EMA). Synthetic phospholipids with specific polar head group, fatty acid composition can be manufactured using various synthesis routes. Synthetic phospholipids with the natural stereochemical configuration are preferably synthesized from glycerophosphocholine (GPC), which is obtained from natural phospholipids, using acylation and enzyme catalyzed reactions. Synthetic phospholipids play compared to natural phospholipid (including hydrogenated phospholipids), as derived from the number of drug products containing synthetic phospholipids, a minor role. Only in a few pharmaceutical products synthetic phospholipids are used. Natural phospholipids are used in oral, dermal, and parenteral products including liposomes. Natural phospholipids instead of synthetic phospholipids should be selected as phospholipid excipients for formulation development, whenever possible, because natural phospholipids are derived from renewable sources and produced with more ecologically friendly processes and are available in larger scale at relatively low costs compared to synthetic phospholipids.
This report aims to provide a comprehensive study of the global market for Phospholipids in Pharmaceutical. Report Highlights:
(1) Global Phospholipids in Pharmaceutical market size (sales volume & revenue), history data from 2018-2022 and forecast data from 2023 to 2029.
(2) Global Phospholipids in Pharmaceutical market competitive situation, sales, revenue, price and market share, from 2018 to 2022.
(3) China Phospholipids in Pharmaceutical market competitive situation, sales, revenue, price and market share, from 2018 to 2022.
(4) Global Phospholipids in Pharmaceutical segment by region (or country), key regions cover the United States, Europe, Japan, South Korea, Southeast Asia and India, etc.
(5) Global Phospholipids in Pharmaceutical segment by type and by application and regional segment by type and by application.
(6) Global major production regions of Phospholipids in Pharmaceutical, capacity, production and trends.
(7) Phospholipids in Pharmaceutical industry supply chain, upstream, midstream and downstream analysis.
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa
Market segment by source, covers
Soy
Egg
Synthetic
Others
Market segment by application, can be divided into
Oral Products
Dermal Products
Parenteral Products
Others
Market segment by players, this report covers
Cargill
Avril
Croda
Lipoid
Nippon Fine Chemical
Sonic Biochem
Nabros Pharma
Vav
NOF
1 Market Overview
1.1 Phospholipids in Pharmaceutical Definition
1.2 Global Phospholipids in Pharmaceutical Market Size and Forecast
1.2.1 By Revenue, Global Phospholipids in Pharmaceutical Market Size, 2018-2029
1.2.2 By Sales Volume, Global Phospholipids in Pharmaceutical Market Size, 2018-2029
1.2.3 Global Phospholipids in Pharmaceutical Price Trend, 2018-2029
1.3 China Phospholipids in Pharmaceutical Market Size and Forecast
1.3.1 By Revenue, China Phospholipids in Pharmaceutical Market Size, 2018-2029
1.3.2 By Sales Volume, China Phospholipids in Pharmaceutical Market Size, 2018-2029
1.3.3 China Phospholipids in Pharmaceutical Price Trend, 2018-2029
1.4 China Percentage in Global Market
1.4.1 By Revenue, China Phospholipids in Pharmaceutical Share in Global Market, 2018-2029
1.4.2 By Sales Volume, China Phospholipids in Pharmaceutical Share in Global Market, 2018-2029
1.4.3 Phospholipids in Pharmaceutical Market Size: China VS Global, 2018-2029
1.5 Phospholipids in Pharmaceutical Market Dynamics
1.5.1 Phospholipids in Pharmaceutical Market Drivers
1.5.2 Phospholipids in Pharmaceutical Market Restraints
1.5.3 Phospholipids in Pharmaceutical Industry Trends
1.5.4 Phospholipids in Pharmaceutical Industry Policy
2 Global Competitive Landscape by Company
2.1 Global Phospholipids in Pharmaceutical Revenue by Company, 2018-2023
2.2 Global Phospholipids in Pharmaceutical Sales Volume by Company, 2018-2023
2.3 Global Phospholipids in Pharmaceutical Price by Company, 2018-2023
2.4 Global Phospholipids in Pharmaceutical Participants, Market Position (Tier 1, Tier 2 and Tier 3)
2.5 Global Phospholipids in Pharmaceutical Concentration Ratio
2.6 Global Phospholipids in Pharmaceutical Mergers & Acquisitions, Expansion Plans
2.7 Global Phospholipids in Pharmaceutical Manufacturers Product Type
3 China Competitive Landscape by Company
3.1 China Phospholipids in Pharmaceutical Revenue by Company, 2018-2023
3.2 China Phospholipids in Pharmaceutical Sales Volume by Company, 2018-2023
3.3 China Phospholipids in Pharmaceutical Phospholipids in Pharmaceutical Participants, Market Position (Tier 1, Tier 2 and Tier 3)
3.4 China Phospholipids in Pharmaceutical Market, Sales Percentage of Local Players VS Foreign Players (2018-2023)
3.5 Chinese Local Players, Phospholipids in Pharmaceutical Domestic VS Export
3.6 China Market, Phospholipids in Pharmaceutical Import & Export
3.6.1 China Market, Phospholipids in Pharmaceutical Import & Export, 2018-2029
3.6.2 China Phospholipids in Pharmaceutical Import & Export Trends
3.6.3 Main Sources of China Phospholipids in Pharmaceutical Import
3.6.4 Export Destination of China Phospholipids in Pharmaceutical
4 Phospholipids in Pharmaceutical Production by Region
4.1 Global Phospholipids in Pharmaceutical Capacity, Production and Capacity Utilization, 2018-2029
4.2 Global Geographic Distribution of Phospholipids in Pharmaceutical Manufacturers
4.3 Global Major Manufacturers, Phospholipids in Pharmaceutical Capacity Expansion and Future Plans
4.4 Global Phospholipids in Pharmaceutical Capacity by Region
4.5 Global Phospholipids in Pharmaceutical Production by Region
4.5.1 Global Phospholipids in Pharmaceutical Production & Forecast by Region, 2018 VS 2022 VS 2029
4.5.2 Global Phospholipids in Pharmaceutical Production by Region, 2018-2023
4.5.3 Global Phospholipids in Pharmaceutical Production Market Share & Forecast by Region, 2018-2029
5 Industry Chain Analysis
5.1 Phospholipids in Pharmaceutical Industry Chain
5.2 Phospholipids in Pharmaceutical Upstream Analysis
5.2.1 Phospholipids in Pharmaceutical Core Raw Materials
5.2.2 Main Manufacturers of Phospholipids in Pharmaceutical Core Raw Materials
5.3 Midstream Analysis
5.4 Downstream Analysis
5.5 Phospholipids in Pharmaceutical Production Mode
5.6 Phospholipids in Pharmaceutical Procurement Model
5.7 Phospholipids in Pharmaceutical Industry Sales Model and Sales Channels
5.7.1 Phospholipids in Pharmaceutical Sales Model
5.7.2 Phospholipids in Pharmaceutical Typical Distributors
6 Sights by Source
6.1 Phospholipids in Pharmaceutical Classification
6.1.1 Soy
6.1.2 Egg
6.1.3 Synthetic
6.1.4 Others
6.2 By Source, Global Phospholipids in Pharmaceutical Market Size & CAGR, 2018 VS 2022 VS 2029
6.3 By Source, Global Phospholipids in Pharmaceutical Revenue, 2018-2029
6.4 By Source, Global Phospholipids in Pharmaceutical Sales Volume, 2018-2029
6.5 By Source, Global Phospholipids in Pharmaceutical Price, 2018-2029
7 Sights by Application
7.1 Phospholipids in Pharmaceutical Segment by Application
7.1.1 Oral Products
7.1.2 Dermal Products
7.1.3 Parenteral Products
7.1.4 Others
7.2 By Application, Global Phospholipids in Pharmaceutical Market Size & CAGR, 2018 VS 2022 VS 2029
7.3 By Application, Global Phospholipids in Pharmaceutical Revenue, 2018-2029
7.4 By Application, Global Phospholipids in Pharmaceutical Sales Volume, 2018-2029
7.5 By Application, Global Phospholipids in Pharmaceutical Price, 2018-2029
8 Sales Sights by Region
8.1 By Region, Global Phospholipids in Pharmaceutical Market Size, 2018 VS 2022 VS 2029
8.2 By Region, Global Phospholipids in Pharmaceutical Revenue, 2018-2029
8.3 By Region, Global Phospholipids in Pharmaceutical Sales Volume, 2018-2029
8.4 North America
8.4.1 North America Phospholipids in Pharmaceutical Market Size & Forecasts, 2018-2029
8.4.2 By Country, North America Phospholipids in Pharmaceutical Market Size Market Share
8.5 Europe
8.5.1 Europe Phospholipids in Pharmaceutical Market Size & Forecasts, 2018-2029
8.5.2 By Country, Europe Phospholipids in Pharmaceutical Market Size Market Share
8.6 Asia Pacific
8.6.1 Asia Pacific Phospholipids in Pharmaceutical Market Size & Forecasts, 2018-2029
8.6.2 By Country/Region, Asia Pacific Phospholipids in Pharmaceutical Market Size Market Share
8.7 South America
8.7.1 South America Phospholipids in Pharmaceutical Market Size & Forecasts, 2018-2029
8.7.2 By Country, South America Phospholipids in Pharmaceutical Market Size Market Share
8.8 Middle East & Africa
9 Sales Sights by Country Level
9.1 By Country, Global Phospholipids in Pharmaceutical Market Size & CAGR，2018 VS 2022 VS 2029
9.2 By Country, Global Phospholipids in Pharmaceutical Revenue, 2018-2029
9.3 By Country, Global Phospholipids in Pharmaceutical Sales Volume, 2018-2029
9.4 U.S.
9.4.1 U.S. Phospholipids in Pharmaceutical Market Size, 2018-2029
9.4.2 By Company, U.S. Phospholipids in Pharmaceutical Sales Volume Market Share, 2022
9.4.3 By Source, U.S. Phospholipids in Pharmaceutical Market Size, Share, 2022 VS 2029
9.4.4 By Application, U.S. Phospholipids in Pharmaceutical Market Size, Share, 2022 VS 2029
9.5 Europe
9.5.1 Europe Phospholipids in Pharmaceutical Market Size, 2018-2029
9.5.2 By Company, Europe Phospholipids in Pharmaceutical Sales Volume Market Share, 2022
9.5.3 By Source, Europe Phospholipids in Pharmaceutical Market Size, Share, 2022 VS 2029
9.5.4 By Application, Europe Phospholipids in Pharmaceutical Market Size, Share, 2022 VS 2029
9.6 China
9.6.1 China Phospholipids in Pharmaceutical Market Size, 2018-2029
9.6.2 By Company, China Phospholipids in Pharmaceutical Sales Volume Market Share, 2022
9.6.3 By Source, China Phospholipids in Pharmaceutical Market Size, Share, 2022 VS 2029
9.6.4 By Application, China Phospholipids in Pharmaceutical Market Size, Share, 2022 VS 2029
9.7 Japan
9.7.1 Japan Phospholipids in Pharmaceutical Market Size, 2018-2029
9.7.2 By Company, Japan Phospholipids in Pharmaceutical Sales Volume Market Share, 2022
9.7.3 By Source, Japan Phospholipids in Pharmaceutical Market Size, Share, 2022 VS 2029
9.7.4 By Application, Japan Phospholipids in Pharmaceutical Market Size, Share, 2022 VS 2029
9.8 South Korea
9.8.1 South Korea Phospholipids in Pharmaceutical Market Size, 2018-2029
9.8.2 By Company, South Korea Phospholipids in Pharmaceutical Sales Volume Market Share, 2022
9.8.3 By Source, South Korea Phospholipids in Pharmaceutical Market Size, Share, 2022 VS 2029
9.8.4 By Application, South Korea Phospholipids in Pharmaceutical Market Size, Share, 2022 VS 2029
9.9 Southeast Asia
9.9.1 Southeast Asia Phospholipids in Pharmaceutical Market Size, 2018-2029
9.9.2 By Company, Southeast Asia Phospholipids in Pharmaceutical Sales Volume Market Share, 2022
9.9.3 By Source, Southeast Asia Phospholipids in Pharmaceutical Market Size, Share, 2022 VS 2029
9.9.4 By Application, Southeast Asia Phospholipids in Pharmaceutical Market Size, Share, 2022 VS 2029
9.10 India
9.10.1 India Phospholipids in Pharmaceutical Market Size, 2018-2029
9.10.2 By Company, India Phospholipids in Pharmaceutical Sales Volume Market Share, 2022
9.10.3 By Source, India Phospholipids in Pharmaceutical Market Size, Share, 2022 VS 2029
9.10.4 By Application, India Phospholipids in Pharmaceutical Market Size, Share, 2022 VS 2029
9.11 Middle East & Asia
9.11.1 Middle East & Asia Phospholipids in Pharmaceutical Market Size, 2018-2029
9.11.2 By Company, Middle East & Asia Phospholipids in Pharmaceutical Sales Volume Market Share, 2022
9.11.3 By Source, Middle East & Asia Phospholipids in Pharmaceutical Market Size, Share, 2022 VS 2029
9.11.4 By Application, Middle East & Asia Phospholipids in Pharmaceutical Market Size, Share, 2022 VS 2029
10 Manufacturers Profile
10.1 Cargill
10.1.1 Cargill Company Information, Head Office, Market Area and Industry Position
10.1.2 Cargill Phospholipids in Pharmaceutical Models, Specifications and Application
10.1.3 Cargill Phospholipids in Pharmaceutical Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.1.4 Cargill Company Profile and Main Business
10.1.5 Cargill Recent Developments
10.2 Avril
10.2.1 Avril Company Information, Head Office, Market Area and Industry Position
10.2.2 Avril Phospholipids in Pharmaceutical Models, Specifications and Application
10.2.3 Avril Phospholipids in Pharmaceutical Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.2.4 Avril Company Profile and Main Business
10.2.5 Avril Recent Developments
10.3 Croda
10.3.1 Croda Company Information, Head Office, Market Area and Industry Position
10.3.2 Croda Phospholipids in Pharmaceutical Models, Specifications and Application
10.3.3 Croda Phospholipids in Pharmaceutical Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.3.4 Croda Company Profile and Main Business
10.3.5 Croda Recent Developments
10.4 Lipoid
10.4.1 Lipoid Company Information, Head Office, Market Area and Industry Position
10.4.2 Lipoid Phospholipids in Pharmaceutical Models, Specifications and Application
10.4.3 Lipoid Phospholipids in Pharmaceutical Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.4.4 Lipoid Company Profile and Main Business
10.4.5 Lipoid Recent Developments
10.5 Nippon Fine Chemical
10.5.1 Nippon Fine Chemical Company Information, Head Office, Market Area and Industry Position
10.5.2 Nippon Fine Chemical Phospholipids in Pharmaceutical Models, Specifications and Application
10.5.3 Nippon Fine Chemical Phospholipids in Pharmaceutical Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.5.4 Nippon Fine Chemical Company Profile and Main Business
10.5.5 Nippon Fine Chemical Recent Developments
10.6 Sonic Biochem
10.6.1 Sonic Biochem Company Information, Head Office, Market Area and Industry Position
10.6.2 Sonic Biochem Phospholipids in Pharmaceutical Models, Specifications and Application
10.6.3 Sonic Biochem Phospholipids in Pharmaceutical Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.6.4 Sonic Biochem Company Profile and Main Business
10.6.5 Sonic Biochem Recent Developments
10.7 Nabros Pharma
10.7.1 Nabros Pharma Company Information, Head Office, Market Area and Industry Position
10.7.2 Nabros Pharma Phospholipids in Pharmaceutical Models, Specifications and Application
10.7.3 Nabros Pharma Phospholipids in Pharmaceutical Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.7.4 Nabros Pharma Company Profile and Main Business
10.7.5 Nabros Pharma Recent Developments
10.8 Vav
10.8.1 Vav Company Information, Head Office, Market Area and Industry Position
10.8.2 Vav Phospholipids in Pharmaceutical Models, Specifications and Application
10.8.3 Vav Phospholipids in Pharmaceutical Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.8.4 Vav Company Profile and Main Business
10.8.5 Vav Recent Developments
10.9 NOF
10.9.1 NOF Company Information, Head Office, Market Area and Industry Position
10.9.2 NOF Phospholipids in Pharmaceutical Models, Specifications and Application
10.9.3 NOF Phospholipids in Pharmaceutical Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.9.4 NOF Company Profile and Main Business
10.9.5 NOF Recent Developments
11 Conclusion
12 Appendix
12.1 Research Methodology
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Market Estimation Model
12.4 Disclaimer
Tables and Figures
Table 1. Phospholipids in Pharmaceutical Market Size & CAGR: China VS Global, 2018-2029, US$ Million
Table 2. Phospholipids in Pharmaceutical Market Restraints
Table 3. Phospholipids in Pharmaceutical Market Trends
Table 4. Phospholipids in Pharmaceutical Industry Policy
Table 5. Global Phospholipids in Pharmaceutical Revenue by Company, 2018-2023, US$ million
Table 6. Global Phospholipids in Pharmaceutical Revenue Market Share by Company, 2018-2023
Table 7. Global Phospholipids in Pharmaceutical Sales Volume by Company, 2018-2023, (Tons)
Table 8. Global Phospholipids in Pharmaceutical Sales Volume Market Share by Company, 2018-2023
Table 9. Global Phospholipids in Pharmaceutical Price by Company, 2018-2023, (US$/Ton)
Table 10. Global Phospholipids in Pharmaceutical Manufacturers Market Concentration Ratio (CR3 and HHI)
Table 11. Global Phospholipids in Pharmaceutical Mergers & Acquisitions, Expansion Plans
Table 12. Global Phospholipids in Pharmaceutical Manufacturers Product Type
Table 13. China Phospholipids in Pharmaceutical Revenue by Company, 2018-2023, US$ million
Table 14. China Phospholipids in Pharmaceutical Revenue Market Share by Company, 2018-2023
Table 15. China Phospholipids in Pharmaceutical Sales Volume by Company, 2018-2023, (Tons)
Table 16. China Phospholipids in Pharmaceutical Sales Volume Market Share by Company, 2018-2023
Table 17. China Market, Phospholipids in Pharmaceutical Production, Sales, Import and Export, 2018-2029, (Tons)
Table 18. China Phospholipids in Pharmaceutical Import & Export Trends
Table 19. Main Sources of China Phospholipids in Pharmaceutical Import
Table 20. Export Destination of China Phospholipids in Pharmaceutical
Table 21. Global Headquarters and Manufacturing Base of Phospholipids in Pharmaceutical Manufacturers
Table 22. Global Major Manufacturers, Phospholipids in Pharmaceutical Capacity Expansion and Future Plans
Table 23. Global Phospholipids in Pharmaceutical Production & Forecast by Region, 2018 VS 2022 VS 2029, (Tons)
Table 24. Global Phospholipids in Pharmaceutical Production by Region, 2018-2023, (Tons)
Table 25. Global Phospholipids in Pharmaceutical Production Forecast by Region, 2023-2029, (Tons)
Table 26. Global Key Players of Phospholipids in Pharmaceutical Upstream (Raw Materials)
Table 27. Global Phospholipids in Pharmaceutical Typical Customers
Table 28. Phospholipids in Pharmaceutical Typical Distributors
Table 29. By Source, Global Phospholipids in Pharmaceutical Revenue & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 30. By Application, Global Phospholipids in Pharmaceutical Revenue & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 31. By Region, Global Phospholipids in Pharmaceutical Market Size, 2018 VS 2022 VS 2029, US$ Million
Table 32. By Region, Global Phospholipids in Pharmaceutical Revenue, 2018-2029, US$ Million
Table 33. By Region, Global Phospholipids in Pharmaceutical Sales Volume, 2018-2029, (Tons)
Table 34. By Country, Global Phospholipids in Pharmaceutical Revenue & CAGR，2018 VS 2022 VS 2029, US$ Million
Table 35. By Country, Global Phospholipids in Pharmaceutical Revenue, 2018-2029, US$ Million
Table 36. By Country, Global Phospholipids in Pharmaceutical Revenue Market Share, 2018-2029
Table 37. By Country, Global Phospholipids in Pharmaceutical Sales Volume, 2018-2029, (Tons)
Table 38. By Country, Global Phospholipids in Pharmaceutical Sales Volume Market Share, 2018-2029
Table 39. Cargill Company Information, Head Office, Market Area and Industry Position
Table 40. Cargill Phospholipids in Pharmaceutical Models, Specifications and Application
Table 41. Cargill Phospholipids in Pharmaceutical Sales Volume (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin, 2018-2023
Table 42. Cargill Company Profile and Main Business
Table 43. Cargill Recent Developments
Table 44. Avril Company Information, Head Office, Market Area and Industry Position
Table 45. Avril Phospholipids in Pharmaceutical Models, Specifications and Application
Table 46. Avril Phospholipids in Pharmaceutical Sales Volume (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin, 2018-2023
Table 47. Avril Company Profile and Main Business
Table 48. Avril Recent Developments
Table 49. Croda Company Information, Head Office, Market Area and Industry Position
Table 50. Croda Phospholipids in Pharmaceutical Models, Specifications and Application
Table 51. Croda Phospholipids in Pharmaceutical Sales Volume (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin, 2018-2023
Table 52. Croda Company Profile and Main Business
Table 53. Croda Recent Developments
Table 54. Lipoid Company Information, Head Office, Market Area and Industry Position
Table 55. Lipoid Phospholipids in Pharmaceutical Models, Specifications and Application
Table 56. Lipoid Phospholipids in Pharmaceutical Sales Volume (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin, 2018-2023
Table 57. Lipoid Company Profile and Main Business
Table 58. Lipoid Recent Developments
Table 59. Nippon Fine Chemical Company Information, Head Office, Market Area and Industry Position
Table 60. Nippon Fine Chemical Phospholipids in Pharmaceutical Models, Specifications and Application
Table 61. Nippon Fine Chemical Phospholipids in Pharmaceutical Sales Volume (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin, 2018-2023
Table 62. Nippon Fine Chemical Company Profile and Main Business
Table 63. Nippon Fine Chemical Recent Developments
Table 64. Sonic Biochem Company Information, Head Office, Market Area and Industry Position
Table 65. Sonic Biochem Phospholipids in Pharmaceutical Models, Specifications and Application
Table 66. Sonic Biochem Phospholipids in Pharmaceutical Sales Volume (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin, 2018-2023
Table 67. Sonic Biochem Company Profile and Main Business
Table 68. Sonic Biochem Recent Developments
Table 69. Nabros Pharma Company Information, Head Office, Market Area and Industry Position
Table 70. Nabros Pharma Phospholipids in Pharmaceutical Models, Specifications and Application
Table 71. Nabros Pharma Phospholipids in Pharmaceutical Sales Volume (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin, 2018-2023
Table 72. Nabros Pharma Company Profile and Main Business
Table 73. Nabros Pharma Recent Developments
Table 74. Vav Company Information, Head Office, Market Area and Industry Position
Table 75. Vav Phospholipids in Pharmaceutical Models, Specifications and Application
Table 76. Vav Phospholipids in Pharmaceutical Sales Volume (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin, 2018-2023
Table 77. Vav Company Profile and Main Business
Table 78. Vav Recent Developments
Table 79. NOF Company Information, Head Office, Market Area and Industry Position
Table 80. NOF Phospholipids in Pharmaceutical Models, Specifications and Application
Table 81. NOF Phospholipids in Pharmaceutical Sales Volume (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin, 2018-2023
Table 82. NOF Company Profile and Main Business
Table 83. NOF Recent Developments
List of Figure
Figure 1. Phospholipids in Pharmaceutical Picture
Figure 2. By Revenue, Global Phospholipids in Pharmaceutical Market Size and Forecast, 2018-2029, US$ Million
Figure 3. By Sales Volume, Global Phospholipids in Pharmaceutical Market Size and Forecast, 2018-2029, (Tons)
Figure 4. Global Phospholipids in Pharmaceutical Price Trend, 2018-2029, (US$/Ton)
Figure 5. By Revenue, China Phospholipids in Pharmaceutical Market Size and Forecast, 2018-2029, US$ million
Figure 6. By Sales Volume, China Phospholipids in Pharmaceutical Market Size and Forecast, 2018-2029, (Tons)
Figure 7. China Phospholipids in Pharmaceutical Price Trend, 2018-2029 (US$/Ton)
Figure 8. By Revenue, China Phospholipids in Pharmaceutical Share of Global Market, 2018-2029
Figure 9. By Sales Volume, China Phospholipids in Pharmaceutical Share of Global Market, 2018-2029
Figure 10. Global Phospholipids in Pharmaceutical Key Participants, Market Share, 2021 VS 2022 VS 2023
Figure 11. Global Phospholipids in Pharmaceutical Market Share by Company, (Tier 1, Tier 2 and Tier 3), 2022
Figure 12. China Phospholipids in Pharmaceutical Key Participants, Market Share, 2021 VS 2022 VS 2023
Figure 13. China Phospholipids in Pharmaceutical Key Participants, Market Share, 2021 VS 2022 VS 2023
Figure 14. China Phospholipids in Pharmaceutical Revenue, Domestic VS Import Products, Proportion of China Local Players and Foreign Players, 2018-2023
Figure 15. Chinese Local Players, Proportion of Phospholipids in Pharmaceutical Domestic VS Export, 2022
Figure 16. Global Phospholipids in Pharmaceutical Capacity, Production and Capacity Utilization, 2018-2029
Figure 17. Global Phospholipids in Pharmaceutical Capacity Market Share by Region, 2022 VS 2029
Figure 18. Global Phospholipids in Pharmaceutical Production Market Share & Forecast by Region, 2018-2029
Figure 19. Phospholipids in Pharmaceutical Industry Chain
Figure 20. Phospholipids in Pharmaceutical Procurement Model
Figure 21. Phospholipids in Pharmaceutical Sales Model
Figure 22. Phospholipids in Pharmaceutical Sales Channels, Direct Sales and Distribution
Figure 23. Soy
Figure 24. Egg
Figure 25. Synthetic
Figure 26. Others
Figure 27. By Source, Global Phospholipids in Pharmaceutical Revenue, 2018-2029, US$ Million
Figure 28. By Source, Global Phospholipids in Pharmaceutical Revenue Market Share, 2018-2029
Figure 29. By Source, Global Phospholipids in Pharmaceutical Sales Volume, 2018-2029, (Tons)
Figure 30. By Source, Global Phospholipids in Pharmaceutical Sales Volume Market Share, 2018-2029
Figure 31. By Source, Global Phospholipids in Pharmaceutical Price, 2018-2029, (US$/Ton)
Figure 32. Oral Products
Figure 33. Dermal Products
Figure 34. Parenteral Products
Figure 35. Others
Figure 36. By Application, Global Phospholipids in Pharmaceutical Revenue, 2018-2029, US$ Million
Figure 37. By Application, Global Phospholipids in Pharmaceutical Revenue Market Share, 2018-2029
Figure 38. By Application, Global Phospholipids in Pharmaceutical Sales Volume, 2018-2029, (Tons)
Figure 39. By Application, Global Phospholipids in Pharmaceutical Sales Volume Market Share, 2018-2029
Figure 40. By Application, Global Phospholipids in Pharmaceutical Price, 2018-2029, (US$/Ton)
Figure 41. By Region, Global Phospholipids in Pharmaceutical Revenue Market Share, 2018-2029
Figure 42. By Region, Global Phospholipids in Pharmaceutical Sales Volume Market Share, 2018-2029
Figure 43. North America Phospholipids in Pharmaceutical Revenue & Forecasts, 2018-2029, US$ Million
Figure 44. By Country, North America Phospholipids in Pharmaceutical Revenue Market Share, 2022
Figure 45. Europe Phospholipids in Pharmaceutical Revenue & Forecasts, 2018-2029, US$ Million
Figure 46. By Country, Europe Phospholipids in Pharmaceutical Revenue Market Share, 2022
Figure 47. Asia Pacific Phospholipids in Pharmaceutical Revenue & Forecasts, 2018-2029, US$ Million
Figure 48. By Country/Region, Asia Pacific Phospholipids in Pharmaceutical Revenue Market Share, 2022
Figure 49. South America Phospholipids in Pharmaceutical Revenue & Forecasts, 2018-2029, US$ Million
Figure 50. By Country, South America Phospholipids in Pharmaceutical Revenue Market Share, 2022
Figure 51. Middle East & Africa Phospholipids in Pharmaceutical Revenue & Forecasts, 2018-2029, US$ Million
Figure 52. U.S. Phospholipids in Pharmaceutical Sales Volume, 2018-2029, (Tons)
Figure 53. By Company, U.S. Phospholipids in Pharmaceutical Market Share, 2022
Figure 54. By Source, U.S. Phospholipids in Pharmaceutical Sales Volume Market Share, 2022 VS 2029
Figure 55. By Application, U.S. Phospholipids in Pharmaceutical Sales Volume Market Share, 2022 VS 2029
Figure 56. Europe Phospholipids in Pharmaceutical Sales Volume, 2018-2029, (Tons)
Figure 57. By Company, Europe Phospholipids in Pharmaceutical Market Share, 2022
Figure 58. By Source, Europe Phospholipids in Pharmaceutical Sales Volume Market Share, 2022 VS 2029
Figure 59. By Application, Europe Phospholipids in Pharmaceutical Sales Volume Market Share, 2022 VS 2029
Figure 60. China Phospholipids in Pharmaceutical Sales Volume, 2018-2029, (Tons)
Figure 61. By Company, China Phospholipids in Pharmaceutical Market Share, 2022
Figure 62. By Source, China Phospholipids in Pharmaceutical Sales Volume Market Share, 2022 VS 2029
Figure 63. By Application, China Phospholipids in Pharmaceutical Sales Volume Market Share, 2022 VS 2029
Figure 64. Japan Phospholipids in Pharmaceutical Sales Volume, 2018-2029, (Tons)
Figure 65. By Company, Japan Phospholipids in Pharmaceutical Market Share, 2022
Figure 66. By Source, Japan Phospholipids in Pharmaceutical Sales Volume Market Share, 2022 VS 2029
Figure 67. By Application, Japan Phospholipids in Pharmaceutical Sales Volume Market Share, 2022 VS 2029
Figure 68. South Korea Phospholipids in Pharmaceutical Sales Volume, 2018-2029, (Tons)
Figure 69. By Company, South Korea Phospholipids in Pharmaceutical Market Share, 2022
Figure 70. By Source, South Korea Phospholipids in Pharmaceutical Sales Volume Market Share, 2022 VS 2029
Figure 71. By Application, South Korea Phospholipids in Pharmaceutical Sales Volume Market Share, 2022 VS 2029
Figure 72. Southeast Asia Phospholipids in Pharmaceutical Sales Volume, 2018-2029, (Tons)
Figure 73. By Company, Southeast Asia Phospholipids in Pharmaceutical Market Share, 2022
Figure 74. By Source, Southeast Asia Phospholipids in Pharmaceutical Sales Volume Market Share, 2022 VS 2029
Figure 75. By Application, Southeast Asia Phospholipids in Pharmaceutical Sales Volume Market Share, 2022 VS 2029
Figure 76. India Phospholipids in Pharmaceutical Sales Volume, 2018-2029, (Tons)
Figure 77. By Company, India Phospholipids in Pharmaceutical Market Share, 2022
Figure 78. By Source, India Phospholipids in Pharmaceutical Sales Volume Market Share, 2022 VS 2029
Figure 79. By Application, India Phospholipids in Pharmaceutical Sales Volume Market Share, 2022 VS 2029
Figure 80. Middle East & Asia Phospholipids in Pharmaceutical Sales Volume, 2018-2029, (Tons)
Figure 81. By Company, Middle East & Asia Phospholipids in Pharmaceutical Market Share, 2022
Figure 82. By Source, Middle East & Asia Phospholipids in Pharmaceutical Sales Volume Market Share, 2022 VS 2029
Figure 83. By Application, Middle East & Asia Phospholipids in Pharmaceutical Sales Volume Market Share, 2022 VS 2029
Figure 84. Research Methodology
Figure 85. Breakdown of Primary Interviews
Figure 86. Bottom-up Approaches
Figure 87. Top-down Approaches
Reason to Buy
- Current and future of Chemical & Material Market outlook in the developed and emerging markets
- Highlights key business priorities in order to assist companies to realign their business strategies
- The segment that is expected to dominate the Chemical & Material Market
- Regions that are expected to witness the fastest growth during the forecast period
- Identify the latest developments, Chemical & Material Market shares, and strategies employed by the major market players
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Chemical & Material Market
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets